News | September 27, 2024
Torrent Pharmaceuticals refutes claims of Shelcal 500 allegedly failing CDSCO quality test
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
The sample seized by CDSCO is not manufactured by Torrent and is in fact non-genuine and spurious
Aragen Life Sciences is the first Indian CRDMO to receive SBTi approval
At 10 years, more than one-third (34.0%) of patients with advanced melanoma were alive after treatment with KEYTRUDA, compared to 23.6% of patients treated with ipilimumab
The publication serves as a foundational tool for identifying gaps and addressing needs in various areas, including rural, urban, and tribal regions
Winrevair is the first activin signaling inhibitor therapy for PAH approved in Europe
Revenue up 16.3% to Rs 5,600 crore versus Rs 4,814 crore
The HD21 study adds to the body of evidence supporting ADCETRIS as a backbone agent in the treatment of specific lymphomas
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
2024 full-year revenue guidance raised by US$ 2 billion
Highly effective preservation solutions ensuring the safety and protection of personal care products
Subscribe To Our Newsletter & Stay Updated
